215 related articles for article (PubMed ID: 28951629)
1. Diagnostic Value of the Methylation of Multiple Gene Promoters in Serum in Hepatitis B Virus-Related Hepatocellular Carcinoma.
Dong X; Hou Q; Chen Y; Wang X
Dis Markers; 2017; 2017():2929381. PubMed ID: 28951629
[TBL] [Abstract][Full Text] [Related]
2. Combination of serum RASSF1A methylation and AFP is a promising non-invasive biomarker for HCC patient with chronic HBV infection.
Dong X; He H; Zhang W; Yu D; Wang X; Chen Y
Diagn Pathol; 2015 Aug; 10():133. PubMed ID: 26238200
[TBL] [Abstract][Full Text] [Related]
3. Methylated cysteine dioxygenase-1 gene promoter in the serum is a potential biomarker for hepatitis B virus-related hepatocellular carcinoma.
Yang Y; Fan YC; Gao S; Dou CY; Zhang JJ; Sun FK; Wang K
Tohoku J Exp Med; 2014 Mar; 232(3):187-94. PubMed ID: 24646840
[TBL] [Abstract][Full Text] [Related]
4. Hypomethylated Ubiquitin-Conjugating Enzyme2 Q1 (UBE2Q1) Gene Promoter in the Serum Is a Promising Biomarker for Hepatitis B Virus-Associated Hepatocellular Carcinoma.
Hu N; Fan XP; Fan YC; Chen LY; Qiao CY; Han LY; Wang K
Tohoku J Exp Med; 2017 Jun; 242(2):93-100. PubMed ID: 28592717
[TBL] [Abstract][Full Text] [Related]
5. Combined detection of insulin-like growth factor-binding protein 7 promoter methylation improves the diagnostic efficacy of AFP in hepatitis B virus-associated hepatocellular carcinoma.
Tao LP; Fan XP; Fan YC; Zhao J; Gao S; Wang K
Pathol Res Pract; 2018 Jan; 214(1):144-150. PubMed ID: 29108923
[TBL] [Abstract][Full Text] [Related]
6. Hypermethylation of secreted frizzled related protein 2 gene promoter serves as a noninvasive biomarker for HBV-associated hepatocellular carcinoma.
Xiang L; Chen LM; Zhai YJ; Sun WJ; Yang JR; Fan YC; Wang K
Life Sci; 2021 Apr; 270():119061. PubMed ID: 33454364
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic and Prognostic Roles of Serum Osteopontin and Osteopontin Promoter Polymorphisms in Hepatitis B-related Hepatocellular Carcinoma.
Chimparlee N; Chuaypen N; Khlaiphuengsin A; Pinjaroen N; Payungporn S; Poovorawan Y; Tangkijvanich P
Asian Pac J Cancer Prev; 2015; 16(16):7211-7. PubMed ID: 26514514
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic Value of the Hypomethylation of the WISP1 Promoter in Patients with Hepatocellular Carcinoma Associated with Hepatitis B Virus.
Chen LM; Xiang L; Sun WJ; Zhai YJ; Gao S; Fan YC; Wang K
Tohoku J Exp Med; 2020 Dec; 252(4):297-307. PubMed ID: 33239483
[TBL] [Abstract][Full Text] [Related]
9. Serum SOX11 promoter methylation is a novel biomarker for the diagnosis of Hepatitis B virus-related hepatocellular carcinoma.
Teng Y; Fan YC; Mu NN; Zhao J; Sun FK; Wang K
Neoplasma; 2016; 63(3):419-26. PubMed ID: 26925788
[TBL] [Abstract][Full Text] [Related]
10. Hepatocellular carcinoma suppressor 1 promoter hypermethylation in serum. A diagnostic and prognostic study in hepatitis B.
Tian MM; Fan YC; Zhao J; Gao S; Zhao ZH; Chen LY; Wang K
Clin Res Hepatol Gastroenterol; 2017 Mar; 41(2):171-180. PubMed ID: 28189396
[TBL] [Abstract][Full Text] [Related]
11. DNA methylation markers and serum α-fetoprotein level are prognostic factors in hepatocellular carcinoma.
Lin JC; Wu YC; Wu CC; Shih PY; Wang WY; Chien YC
Ann Hepatol; 2015; 14(4):494-504. PubMed ID: 26019036
[TBL] [Abstract][Full Text] [Related]
12. MT1M and MT1G promoter methylation as biomarkers for hepatocellular carcinoma.
Ji XF; Fan YC; Gao S; Yang Y; Zhang JJ; Wang K
World J Gastroenterol; 2014 Apr; 20(16):4723-9. PubMed ID: 24782625
[TBL] [Abstract][Full Text] [Related]
13. microRNA-150: a promising novel biomarker for hepatitis B virus-related hepatocellular carcinoma.
Yu F; Lu Z; Chen B; Dong P; Zheng J
Diagn Pathol; 2015 Jul; 10():129. PubMed ID: 26215970
[TBL] [Abstract][Full Text] [Related]
14. Aberrant DNA methylation of G-protein-coupled bile acid receptor Gpbar1 (TGR5) is a potential biomarker for hepatitis B Virus associated hepatocellular carcinoma.
Han LY; Fan YC; Mu NN; Gao S; Li F; Ji XF; Dou CY; Wang K
Int J Med Sci; 2014; 11(2):164-71. PubMed ID: 24465162
[TBL] [Abstract][Full Text] [Related]
15. RASSF1A and SOCS1 genes methylation status as a noninvasive marker for hepatocellular carcinoma.
Pasha HF; Mohamed RH; Radwan MI
Cancer Biomark; 2019; 24(2):241-247. PubMed ID: 30689554
[TBL] [Abstract][Full Text] [Related]
16. Exportin 4 gene expression and DNA promoter methylation status in chronic hepatitis B virus infection.
Zhang F; Fan YC; Mu NN; Zhao J; Sun FK; Zhao ZH; Gao S; Wang K
J Viral Hepat; 2014 Apr; 21(4):241-50. PubMed ID: 24597692
[TBL] [Abstract][Full Text] [Related]
17. Hepatic miR-126 is a potential plasma biomarker for detection of hepatitis B virus infected hepatocellular carcinoma.
Ghosh A; Ghosh A; Datta S; Dasgupta D; Das S; Ray S; Gupta S; Datta S; Chowdhury A; Chatterjee R; Mohapatra SK; Banerjee S
Int J Cancer; 2016 Jun; 138(11):2732-44. PubMed ID: 26756996
[TBL] [Abstract][Full Text] [Related]
18. Hypomethylation of the cyclin D1 promoter in hepatitis B virus-associated hepatocellular carcinoma.
Liu HH; Fang Y; Wang JW; Yuan XD; Fan YC; Gao S; Han LY; Wang K
Medicine (Baltimore); 2020 May; 99(20):e20326. PubMed ID: 32443384
[TBL] [Abstract][Full Text] [Related]
19. Cell-free methylation markers with diagnostic and prognostic potential in hepatocellular carcinoma.
Lu CY; Chen SY; Peng HL; Kan PY; Chang WC; Yen CJ
Oncotarget; 2017 Jan; 8(4):6406-6418. PubMed ID: 28031532
[TBL] [Abstract][Full Text] [Related]
20. Sera DNA Methylation of CDH1, DNMT3b and ESR1 Promoters as Biomarker for the Early Diagnosis of Hepatitis B Virus-Related Hepatocellular Carcinoma.
Dou CY; Fan YC; Cao CJ; Yang Y; Wang K
Dig Dis Sci; 2016 Apr; 61(4):1130-8. PubMed ID: 26660680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]